ANXA3基因及蛋白的研究进展
投稿时间:2023-09-13  修订日期:2024-02-22  点此下载全文
引用本文:冯婷婷,张景翔,王彦,许维恒,张俊平.ANXA3基因及蛋白的研究进展[J].药学实践杂志,2025,43(2):47~50,74
摘要点击次数: 66
全文下载次数: 0
作者单位E-mail
冯婷婷 福建中医药大学药学院, 福建 福州 350108  
张景翔 海军军医大学药学系, 上海 200433  
王彦 海军军医大学药学系, 上海 200433  
许维恒 海军军医大学药学系, 上海 200433  
张俊平 福建中医药大学药学院, 福建 福州 350108
海军军医大学药学系, 上海 200433 
jpzhang@163.com 
中文摘要:膜联蛋白A3(ANXA3)属于膜联蛋白家族成员,具有36 kDa和33 kDa两个亚型,其基因位于人第4号染色体上。ANXA3在人体骨髓、肺、胎盘、前列腺和甲状腺等组织中表达,与胞吐、血管生成、脂肪细胞成熟和白细胞迁移等生物学过程密切相关。研究发现,ANXA3在癌症、心血管疾病和炎症等疾病中异常表达,可以调控JNK、NF-κB、PI3K/Akt等多条信号通路,可能成为相关疾病的治疗靶点。该文主要就ANXA3的结构、功能、与疾病的联系以及相关机制进行综述,以期为ANXA3的相关研究提供借鉴。
中文关键词:膜联蛋白A3  结构功能  疾病机制
 
Research progress on ANXA3 gene and protein
Abstract:Annexin A3(ANXA3)is a member of the membrane associated protein family. It has two subtypes of 36 kDa and 33 kDa. Its gene is located on the fourth chromosome of human. ANXA3, widely expressed in human bone marrow, lung, placenta, prostate and thyroid, is closely related to several biological processes such as exoplasmosis, vascular production, fat cell maturity, and white blood cell migration. Studies have found that ANXA3 is abnormally expressed in various diseases including cancer, cardiovascular disease and inflammation. It can regulate multiple signaling pathways such as JNK, NF-κB, PI3K/AKT, and may become a potential drug target for treatment of related diseases. The structure, functions, the link with diseases and related mechanisms of ANXA3 were summarized in this paper, which could provide reference for ANXA3 related research.
keywords:Annexin A3  structural function  disease mechanism
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮